Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoEarlier in the year, one analyst called results from the cancer vaccine study "transformational."...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 1 day agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Morningstar· 2 days agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE, MA / ACCESSWIRE ...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 2 days agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 3 days agoVaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were prepared to make...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 4 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 6 days agoAbrysvo has since been expanded and is now approved as a maternal vaccine that protects newborn...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 6 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented ...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks· 5 days agoShares of COVID-19 vaccine developers rose on Monday after the FDA issued briefing documents for its Vaccines and Related Biological Products Advisory Committee ...